Transdermal nicotine after smoking cessation.
Pine
D S
DS
Hatterer
J
J
D000279:Administration, Cutaneous; D002638:Chewing Gum; D003866:Depressive Disorder / Q000517:prevention & control* / Q000523:psychology; D005260:Female; D006801:Humans; D008862:Microsomes, Liver / Q000201:enzymology; D008875:Middle Aged; D009538:Nicotine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives / Q000627:therapeutic use*; D011109:Polymethacrylic Acids / Q000627:therapeutic use; D011145:Polyvinyls / Q000627:therapeutic use; D012907:Smoking / Q000523:psychology; D016540:Smoking Cessation; D000074606:Smoking Prevention; D013375:Substance Withdrawal Syndrome / Q000209:etiology / Q000517:prevention & control; D061485:Tobacco Use Cessation Devices
D002638:Chewing Gum; D011109:Polymethacrylic Acids; D011145:Polyvinyls; D009538:Nicotine